W
TTHI

Wealthfront’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Wealthfront’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7
Closed – – 1616
2015
Q2 		$0 Buy
+7
New +$49 ﹤0.01% 1471

Other funds holding TTHI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
NC
NBW Capital Boston, Massachusetts $464M AUM 21.25% 1-Year Est. Return

Wealthfront's TTHI Position: Q3 2015 in Review

Wealthfront sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2015, closing a stake of 7 shares.

Wealthfront first reported a position in TTHI in Q2 2015 and held it in 1 quarter. The position peaked at $0 in Q2 2015. 26 funds tracked by Wall St. Rank hold TTHI as of Q3 2015.

  • Wealthfront reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2015 after selling out during the quarter.
  • Wealthfront sold 7 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2015.
  • Wealthfront first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2015 and held it in 1 quarter.
  • Wealthfront's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $0 in Q2 2015.
  • 26 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2015.

Based on Wealthfront's 13F filing for Q3 2015, filed 18 Nov 2015.